CTOs on the Move

MedRep Surgical Inc

www.medrepsurgical.com

 
MedRep Surgical Inc is a Minnesota, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Mission Athletecare

MISSION is the first and only line of athlete-engineered products designed to enhance performance in training and competition. Co-founded in 2009 by a premier group of world-class athletes including Serena Williams, Dwyane Wade, Sergio Garcia, David Wright, Reggie Bush and Mia Hamm, MISSION boasts more than 25 high-performance product innovations and is sold in nearly 20,000 stores across the U.S. MISSION works with its world-renowned athletes, doctors and scientists to engineer products that help athletes prepare, perform and rehab from training or competition.

A.T. Radiology

A.T. Radiology is a diagnostic imaging provider with locations in Winter Haven, Davenport, and Lake Wales, Florida. They provide exceptional radiology and diagnostic services for patients and referring physicians throughout Florida.

AK Martial Arts & Fitness

Award winning martial arts. RealFit4Life Building, Bressi Ranch Carlsbad. Accredited with the Traditional Tang Soo Do Federation. Dedicated to our community.

Xymogen

Xymogen is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.